Roche Diabetes Care Archives - Medical Design Sourcing

The biggest diabetes tech news out of ATTD 2024

This is a screenshot from a video demonstrating the features of the new Roche Accu-Chek SmartGuide CGM at ATTD 2024.

Every year, the diabetes community comes together for the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD).

In the 17th installment at the start of this month, some of the biggest names shared new studies and technologies set to advance the diabetes space. Dexcom, Abbott, Medtronic and more contributed on their end, while some new technologies are coming to the fore as well.

Here are the biggest stories from this year’s ATTD conference in Florence, Italy. (You can also check out the biggest news out of ATTD in 2023 and 2022.)

Dexcom’s direct-to-watch feature

Dexcom announced at ATTD that it introduced a direct-to-Apple-Watch feature for its G7 continuous glucose monitor (CGM) users.

The company plans a phased launch for all G7 iOS users everywhere by the end of the second quarter of …

Roche unveils new CGM tech with predictive AI, outlines diabetes strategy

This is a screenshot from a video demonstrating the features of the new Roche Accu-Chek SmartGuide CGM at ATTD 2024.

Roche today gave a presentation debuting its first continuous glucose monitor (CGM) offering that utilizes predictive AI.

The company unveiled its Accu-Chek SmartGuide in an event at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Florence, Italy. It remains an investigational device not yet authorized for sale.

Julien Boisdron, Roche Diabetes Care’s chief medical officer, called it “a solution more than a CGM” during the event. He explained that, comprised of a sensor and two applications, the offering helps visualize data and make predictions as well.

Jochen Berchtold, VP and franchise lead for insulin therapy solutions at Roche Diabetes, highlighted the power of that combination.

“We think that the combination of the strength of a CGM, plus the power of prediction, has the poss…

Insulet sues Roche over diabetes tech patent

Insulet (NSDQ:PODD) is suing Roche Diabetes Care in the U.K., claiming that Roche prematurely began selling tubeless insulin pumps covered by an Insulet patent three years before that patent expires.

The trial for the lawsuit, filed in August 2020, began this week in the U.K. High Court.

Get the full story on our sister site, Drug Delivery Business News.

BioCorp, Roche launch Mallya smart insulin pen in France

BioCorp and Roche Diabetes Care France announced the launch of the Mallya smart insulin pen device in France.

Developed by BioCorp, Mallya is an intelligent sensor for insulin injection pens that has CE mark approval in Europe. The platform is compatible with any disposable insulin pen. It enables reliable monitoring for doses selected for injection and it offers patients with diabetes better compliance with their treatment, according to the companies.

Get the full story at our sister site, Drug Delivery Business News.